GlassScriptPhysician profile
Andrei Gursky
NPI 1790753515
$6,708.89
in general payments reported to CMS, 2019-2025
20 companies · $581 in 2025
The $581 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.24 · 2020: $274 · 2021: $2,689 · 2022: $1,366 · 2023: $969 · 2024: $773 · 2025: $581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,323.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $1,499.53 | 2021-2024 | Auryon Laser System 100-120 Vac |
| Philips North America LLC | $1,468.57 | 2022-2025 | (Br5) Peripheral Ivus, Igt Devices Systems Undivided, IV Other |
| Bard Peripheral Vascular, INC. | $1,142.24 | 2020-2025 | Rotarexs 6 F X 135 Cm, Venovo |
| Abbott Laboratories | $545.65 | 2021-2024 | Supera, Diamondback Peripheral, Armada |
| Cook Medical LLC | $477.11 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $472.94 | 2020-2022 | |
| Terumo Medical Corporation | $268.58 | 2022-2025 | Angio-Seal, Glidewire, Navicross |
| Boston Scientific Corporation | $166.21 | 2023-2025 | Varithena Administration Pack |
| Cordis US Corp. | $164.53 | 2022-2023 | Rain Sheath Transradial |
| Tactile Systems Technology INC | $143.85 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Medtronic, INC. | $118.91 | 2024 | Closurerfs |
| Cardiovascular Systems INC. | $68.48 | 2022 | |
| Cashflow Solutions, LLC | $35.09 | 2023 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Innovation Technologies INC | $28.36 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.54 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $20.90 | 2023 | Opsumit |
| Venturemed Group, INC. | $20.50 | 2021 | |
| Inari Medical, INC. | $18.15 | 2022 | |
| Celonova Biosciences, INC. | $17.13 | 2021 | |
| Reflow Medical INC | $10.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrei Gursky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.